News Industry News FDA Approves First Implantable Wireless Device with Remote Monitoring to Measure Pulmonary Artery Pressure in Certain Heart Failure Patients May 28, 2014
News Daily News Over the Long Haul, TAVR Appears Better Than Surgery for Women Caitlin E. Cox February 19, 2014
News Daily News Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente Yael L. Maxwell February 13, 2014
News Daily News FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications Yael L. Maxwell February 13, 2014
News Daily News Watchman Wins Substantial Endorsement from FDA Advisory Panel Yael L. Maxwell January 01, 2014
News Daily News Watchman Logra un Apoyo Importante del Panel de Asesores de la FDA Yael L. Maxwell January 01, 2014
News Industry News FDA Advisory Panel Votes Favorably on the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device December 10, 2013
News Daily News Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options March 25, 2013
News Daily News Panel de cierre de la FDA vota a favor del MitraClip para pacientes con RM que no tienen otras opciones March 25, 2013
News Industry News FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery March 20, 2013
News Industry News Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery March 09, 2013
News Daily News Zilver Stent Seen as Welcome Addition to PAD Armamentarium L.A. McKeown November 25, 2012
News Daily News Stent Zilver parece ser una adición bienvenida al arsenal de PAD L.A. McKeown November 25, 2012
News Daily News Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib L.A. McKeown August 09, 2012
News Daily News La Votación de un Panel de la FDA para la Expansión de la TAVR Anima a los Defensores de este Procedimiento June 19, 2012
News Industry News FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome May 23, 2012